| Dr Megan Elaine Mcdonald, MD | |
|
200 Hawkins Dr, Iowa City, IA 52242 | |
| (319) 356-2015 | |
| (319) 353-8363 |
| Full Name | Dr Megan Elaine Mcdonald |
|---|---|
| Gender | Female |
| Speciality | Gynecological Oncology |
| Experience | 13 Years |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043505852 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State University Of Iowa | 7618884230 | 1476 |
News Archive
Seniors who consume a higher level of dietary protein are less likely to suffer hip fractures than seniors whose daily dietary protein intake is less, according to a new study by the Institute for Aging Research of Hebrew SeniorLife in Boston, an affiliate of Harvard Medical School.
An international collaboration led by clinical researchers at the Wellcome Trust Sanger Institute has shown proof-of-concept that truly personalised therapy will be possible in the future for people with cancer.
QuantumMethod announced today that Lerner Medical Devices, Inc. has selected the firm as agency of record, tasked with branding and launching Levia®, the company's new Personal Targeted Phototherapy™ device for the self-treatment of psoriasis. Levia® enables their patients to target their small area and scalp psoriasis with therapeutic ultraviolet light via proprietary delivery systems designed for precise, fast and safe treatment.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).
A world-famous psychological experiment used to help explain the brain's understanding of the body, as well as scores of clinical disorders, has been dismissed as not fit-for-purpose in a new academic paper from the University of Sussex.
› Verified 3 days ago
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
Seniors who consume a higher level of dietary protein are less likely to suffer hip fractures than seniors whose daily dietary protein intake is less, according to a new study by the Institute for Aging Research of Hebrew SeniorLife in Boston, an affiliate of Harvard Medical School.
An international collaboration led by clinical researchers at the Wellcome Trust Sanger Institute has shown proof-of-concept that truly personalised therapy will be possible in the future for people with cancer.
QuantumMethod announced today that Lerner Medical Devices, Inc. has selected the firm as agency of record, tasked with branding and launching Levia®, the company's new Personal Targeted Phototherapy™ device for the self-treatment of psoriasis. Levia® enables their patients to target their small area and scalp psoriasis with therapeutic ultraviolet light via proprietary delivery systems designed for precise, fast and safe treatment.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).
A world-famous psychological experiment used to help explain the brain's understanding of the body, as well as scores of clinical disorders, has been dismissed as not fit-for-purpose in a new academic paper from the University of Sussex.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Megan Elaine Mcdonald, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-2015 | Dr Megan Elaine Mcdonald, MD 200 Hawkins Dr, Iowa City, IA 52242 Ph: (319) 356-2015 |
News Archive
Seniors who consume a higher level of dietary protein are less likely to suffer hip fractures than seniors whose daily dietary protein intake is less, according to a new study by the Institute for Aging Research of Hebrew SeniorLife in Boston, an affiliate of Harvard Medical School.
An international collaboration led by clinical researchers at the Wellcome Trust Sanger Institute has shown proof-of-concept that truly personalised therapy will be possible in the future for people with cancer.
QuantumMethod announced today that Lerner Medical Devices, Inc. has selected the firm as agency of record, tasked with branding and launching Levia®, the company's new Personal Targeted Phototherapy™ device for the self-treatment of psoriasis. Levia® enables their patients to target their small area and scalp psoriasis with therapeutic ultraviolet light via proprietary delivery systems designed for precise, fast and safe treatment.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).
A world-famous psychological experiment used to help explain the brain's understanding of the body, as well as scores of clinical disorders, has been dismissed as not fit-for-purpose in a new academic paper from the University of Sussex.
› Verified 3 days ago
Sofia Gabrilovich, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 813-416-4223 | |
Ashley Kaiser, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Obgyn, Iowa City, IA 52242 Phone: 319-356-2294 Fax: 319-356-7533 | |
Barrie Anderson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, University Of Iowa Hospitals & Clinics, Iowa City, IA 52242 Phone: 319-356-2015 Fax: 319-353-8363 | |
Dr. Margaret Long Foster, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr Dept Obgyn, Iowa City, IA 52242 Phone: 319-356-2294 Fax: 319-384-8620 | |
Dr. Garrett K. Lam, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1616 Fax: 319-356-2133 | |
Dr. Christopher D Clark, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2294 Fax: 319-384-9693 |